Evidence map›Paper›PMID 38472706›Full record

ArticleObesity surgery2024

Indications and Coverage of Metabolic and Bariatric Surgery: A Worldwide IFSO Survey Comparing Different National Guidelines.

J Pujol-Rafols, J Carmona-Maurici, D M Felsenreich, S A Shikora, G Prager, N Di Lorenzo, M De Luca, O Uyanik, M Mazzarella, S D'Arco and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Obesity surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Endoscopic sleeve gastroplastyWorld journal of gastrointestinal surgery · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

J Pujol-Rafols *Metabolic and Bariatric Surgery Unit (UCOM), Clínica Mi Tres Torres and Hospital HM Delfos, Barcelona, Spain. juan.pujol.rafols@gmail.com.
J Carmona-MauriciDepartament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.
D M FelsenreichDivision of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria.
S A ShikoraHarvard Medical School, Department of Surgery Brigham and Women's Hospital, Boston, MA, USA.
G PragerDivision of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria.
N Di LorenzoDept. of Surgical Sciences, Università di Roma Tor Vergata, Roma, Italy.
M De LucaDepartment of Surgery, Rovigo Hospital, Italy.
O UyanikDepartment of General and Digestive Surgery, Hospital Consorci Alt Penedes i Garraf, Hospital Residencia Sant Camil, Sant Pere de Ribes, Barcelona, Spain.
M MazzarellaIFSO Headquarters, Naples, Italy.
S D'ArcoIFSO Headquarters, Naples, Italy.
L AngrisaniDepartment of Public Health, Federico II" University of Naples, Naples, Italy.
E Pardina *Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.
J M Balibrea *Endocrine, Metabolic and Bariatric Surgery Unit, Department of Surgery, Germans Trias i Pujol University Hospital, Badalona, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionKnowing how metabolic and bariatric surgery (MBS) is indicated in different countries is essential information for the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).

aimTo analyze the indications for MBS recommended by each of the national societies that comprise the IFSO and how MBS is financed in their countries.

methodsAll IFSO societies were asked to fill out a survey asking whether they have, and which are their national guidelines, and if MBS is covered by their public health service.

resultsSixty-three out of the 72 IFSO national societies answered the form (87.5%). Among them, 74.6% have some kind of guidelines regarding indications for MBS. Twenty-two percent are still based on the US National Institute of Health (NIH) 1991 recommendations, 43.5% possess guidelines midway the 1991s and ASMBS/IFSO 2022 ones, and 34% have already adopted the latest ASMBS/IFSO 2022 guidelines. MBS was financially covered in 65% of the countries.

conclusionsMost of the IFSO member societies have MBS guidelines. While more than a third of them have already shifted to the most updated ASMBS/IFSO 2022 ones, another significant number of countries are still following the NIH 1991 guidelines or even do not have any at all. Besides, there is a significant number of countries in which surgical treatment is not yet financially covered. More effort is needed to standardize indications worldwide and to influence insurers and health policymakers to increase the coverage of MBS.

Indexed as

Bariatric SurgeryMetabolic DiseasesObesity, MorbidHumansObesitySocieties, MedicalASMBSBariatric surgeryCoverageGuidelinesIFSOIndicationsMetabolic surgery

Identifiers

PMID38472706

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.